MGO One Seven’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

MGO One Seven’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-589	Closed	-$3.43K	–	908
2023 Q2	$3.43K	Hold	589	–	–	﹤0.01%	788
2023 Q1	$22.3K	Hold	589	–	–	﹤0.01%	854
2022 Q4	$17.6K	Hold	589	–	–	﹤0.01%	728
2022 Q3	$19	Hold	589	–	–	﹤0.01%	708
2022 Q2	$24K	Hold	589	–	–	﹤0.01%	636
2022 Q1	$31K	Hold	589	–	–	﹤0.01%	668
2021 Q4	$33K	Hold	589	–	–	﹤0.01%	661
2021 Q3	$44K	Hold	589	–	–	0.01%	599
2021 Q2	$76K	Hold	589	–	–	0.01%	582
2021 Q1	$96K	Sell	589 -211	-26%	-$40.6K	0.02%	538
2020 Q4	$187K	Hold	800	–	–	0.04%	461
2020 Q3	$83K	Buy	+800	New	+$42.8K	0.02%	458

Other funds holding TCON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

MGO One Seven's TCON Position: Q3 2023 in Review

MGO One Seven sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q3 2023, closing a stake of 589 shares — an estimated $3.43K sold.

MGO One Seven first reported a position in TCON in Q3 2020 and held it in 12 quarters. The position peaked at $187K in Q4 2020. 21 funds tracked by Wall St. Rank hold TCON as of Q3 2023.

MGO One Seven reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
MGO One Seven sold 589 TRACON Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $3.43K.
MGO One Seven first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
MGO One Seven's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $187K in Q4 2020.
21 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on MGO One Seven's 13F filing for Q3 2023, filed 3 Nov 2023.